Abstract:SUMMARY Azithromycin (AZI) is a broad-spectrum antibacterial drug popular in the market, however its bitterness seriously limited its application. Coating is the most common method used to obstruct the bitter drugs contact with the taste buds. In this study, a novel polymeric coating composition composed of Eudragit RL 30D and Eudragit L30D-55 was used to coat AZI pellets for taste-masking. Due to the enteric properties of the coating film, no drug was released intraorally (pH 5.0) until the environment pH was lowered to 1.0 (gastric environment). The result indicated the combination of these two acrylic polymers provided an applicable approach to prepare AZI taste-masked dosage forms. INTRODUCTION Azithromycin(AZI) is a new semi-synthetic macrolide antibiotic derived from erythromycin. It is popular in the antibiotic product market due to several advantages, including broad-spectrum activity, long elimination half-life, chemical and biological stability, few adverse effects, and short therapeutic time. However, AZI is terribly bitter which reduces the patient compliance and limits its application. Therefore, it is necessary to develop AZI taste-masked dosage forms. The ideal taste-masked dosage form can specifically inhibit the bad taste (such as bitterness), but not affect other taste percepts (such as sweetness), as well as not change the drug bioavailability. By far, the taste-masking mechanisms can be summarized as following: (1) adding flavor agents to make taste buds produce illusion; (2) avoiding direct contact of bitter drugs with taste buds; (3) making the taste buds reversible and temporary paralysis; and (4) competing the bitter receptors to block bitter signals to the brain. In this study, coating technique was used to achieve the purpose of taste-masking. At present acrylic resins are mainly used for thin film coating. Among them, Eudragit RL 30D is insoluble but swellable in water and independent of pH, while Eudragit L 30D-55 is an enteric material dissolving in medium with pH above 5.5. Previous study showed when the two polymers were combined at certain ratio, the film property could be shifted from enteric to acid soluble. Taking advantage of this nature, a polymeric coating composition was novelly used for task-masking by simply adding Eudragit RL 30D into Eudragit L 30D-55. EXPERIMENTAL METHODS AZI and Polyvinylpyrrolidone K-90 (PVP K-90) were dissolved in 70% ethanol and sprayed on the microcrystalline cellulose (MCC) pellet cores (0.15-0.20 mm in size) until 20 wt% drug loading was achieved. The drug-layered pellets were dried in oven at 40°C for 4 h, and then sieved manually to collect pellets in size of 0.20-0.25 mm. The surface of pellets was examined by scanning electron microscopy (SEM). Subsequently the drug-loaded pellets were coated in a fluidized bed (bottom spraying) with the combination of Eudragit RL 30D and Eudragit L30D-55 pre-mixed at different ratios. Finally, the coated pellets were dried in oven at 40°C for 4 h, and sieved manually for the product in size of 0.20-0.25 mm. The taste-masking effect of the coated pellets was evaluated through in vitro drug release studies in pH 5.0 PBS and pH 1.0 acid media, which simulated the oral and gastric environment respectively. RESULTS AND DISCUSSION The SEM photographs of the drug-loaded pellets (Figure 1) illustrated the pellets were in uniform size and spheric or spheroidal shapes, which are appropriate for homogeneous coating. Figure 1. SEM photographs of drug-loaded

Studies on the Dissolution Profile of Phosphate Tetramethylpyrazine Sustained-Release Pellets Coated with Eudragit Pseudolatex

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Influence Of An Enteric Polymer On Drug Release Rates Of Theophylline From Pellets Coated With Eudragit (R) Rs 30d

Influence of an Enteric Polymer on Drug Release Rates of Theophylline from Pellets Coated with Eudragit® RS 30D

Study on pramipexole dihydrochloride sustained-release tablets

Sustained release coating of tablets with Eudragit® RS/RL using a novel electrostatic dry powder coating process

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole

Novel Application Method of Talcum Powder to Prevent Sticking Tendency and Modify Release of Esomeprazole Magnesium Enteric-Coated Pellets

Preparation and evaluation of sustained-release diltiazem hydrochloride pellets

Preparation of pH-independent sustained-release pellets of matrine

Influence of Relative Humidity on the Mechanical and Drug Release Properties of Theophylline Pellets Coated with an Acrylic Polymer Containing Methylparaben As a Non-Traditional Plasticizer

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

Eudragit L/HPMCAS Blend Enteric-Coated Lansoprazole Pellets: Enhanced Drug Stability and Oral Bioavailability

Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS

STUDY ON THE PREPARATION OF SUSTAINED-RELEASE AND PULSATILE PELLETS OF DILTIAZEM HYDROCHLORIDE

Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns

Studies on Sustained Release Hydrophilic Matrix Tablets Containing Hydroxypropylmethylceilulose and Carbopol

Floating hot-melt extruded tablets for gastroretentive controlled drug release system

Study on Preparation Technique of Enteric Coating Potassium Sodium Dehydroandroan Drographolide Succinate Pellets

Shifting the Enteric Property of Eudragit L 30 D55 to Taste-masking by Adding Eudraigt RL 30 D

Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating